Check out important updates from the FDA for the week of April 15.

Representatives from the US Government Accountability Office (GAO) interviewed regulators from 5 states on pharmacy benefit manager laws.

Listening carefully to determine what’s beneath the surface of a patient’s concerns can make a world of difference in providing quality care.

A Q&A with Joe McKamey, general manager at Marcrom’s Pharmacy in Manchester, Tennessee.

This approval is the second biosimilar approval for manufacturer Alvotech.

Digital therapeutics are positioned as front-runners in the increasingly digital future of health care.

Nine pharmacists from 2 corporate locations in Wakefield and Westerly are seeking to join the Pharmacy Guild in an attempt to improve working conditions.

Kathy Campbell, PharmD, discusses why she believes wellness and proactive health are the future of pharmacy and the unique value they offer compared to traditional models.

Patients in ED being treated for an opioid overdose were more likely to initiate medication for opioid use disorder after discharge when they received peer recovery support services.

More than half of those who responded to a recent KFF survey say they are worried about paying for their prescription drugs.

Researchers were unable to find a significant benefit for patients for the majority of cancer medications given accelerated FDA approval.

Overall, older adults with diabetes faced a 53% higher risk of developing at least 1 functional limitation during the pandemic compared to older adults without diabetes.

A Q&A with Douglas Hoey, CEO of NCPA, on how the new provision from CMS requiring DIR fees at the point of sale is impacting independent pharmacies in 2024.

The ongoing opioid crisis in the United States shows no signs of slowing down. As trusted community health care professionals, pharmacists must play a key role in fighting it.

With an unprecedented number of Americans in need of mental health care, what role should pharmacists play when it comes to screenings?

With the judge’s failure to approve a settlement class, a $13.5 million settlement against Eli Lilly was called off.

Findings indicating that socioeconomic disparities widened gaps in vaccination timeliness signal the need for increased efforts to promote timely vaccination among children from families with lower income and those without private insurance.

The company’s investigational ABCWY vaccine candidate will be reviewed by the FDA by February 14, 2025.

A study from the Karolinska Institutet found that 76 out of 145410 patients treated with a GLP-1 developed thyroid cancer during nearly 4 years of follow-up.

April showers might bring May flowers, but for some, the month also brings the return of allergy woes. This spring, breathe easy with these OTC allergy product recommendations.

The DEA informed community pharmacists on e-prescribing fraud and measures necessary to detect it.

A study from the Children’s Hospital of Philadelphia found that a positive PCR test was not associated with an increased risk of a new asthma diagnosis in patients ages 1 to 16.

A string of thefts at local pharmacies has spurred the DEA to issue warnings and share tips for independent pharmacists to keep their stores secure.

See what's trending in pharmacy with a preview of the Total Pharmacy April issue.

In the United States, 12 million adults suffer from co-occurring chronic pain and anxiety or depression. Erasing stigmas, educating patients, and tailoring interventions can help to improve outcomes.